Results 221 to 230 of about 260,030 (390)
STIP1 drives Metabolic Reprogramming in Esophageal Squamous Cell Carcinoma via AHCY‐LDHA Axis
A schematic model illustrating that LCA can inhibit ESCC growth by inhibiting the STIP1/AHCY/LDHA axis. In brief. Jin et al. demonstrated that targeting STIP1 can significantly inhibit the progression of esophageal squamous cell carcinoma. The high expression of STIP1 increased the interaction between AHCY and LDHA and then AHCY recruits PRMT3 to ...
Guoguo Jin +16 more
wiley +1 more source
Oncogenic KRAS Activates Hedgehog Signaling Pathway in Pancreatic Cancer Cells [PDF]
Zhenyu Ji +3 more
openalex +1 more source
Schematic overview illustrating the anticancer mechanisms of selected natural products (resveratrol, quercetin, berberine) targeting EGFR and HER2 signaling pathways in tumor cells. These compounds inhibit receptor activation and downstream oncogenic cascades, including PI3K/Akt/mTOR, MAPK/ERK, and STAT3 pathways.
Iman Ramli +8 more
wiley +1 more source
Association of KRAS polymorphisms with risk for lung adenocarcinoma accompanied by atypical adenomatous hyperplasias [PDF]
Takashi Kohno +7 more
openalex +1 more source
Magnifying Glass on Sinonasal NUT Carcinoma Heterogeneity via Spatial Transcriptomics
ABSTRACT Background Nuclear protein in testis (NUT) carcinomas (NCs) are rare, clinically aggressive tumors with characteristic translocation involving NUTM1 and BRD4 genes. While NCs are generally characterized by undifferentiated basaloid cells with focal/abrupt squamous differentiation, tumoral heterogeneity remains unexplored.
Diana Bell +8 more
wiley +1 more source
Zbigniew Kras
doaj +1 more source
KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer [PDF]
Naomi Nakayama +7 more
openalex +1 more source

